Interventional Spine, Inc. Enhances Percutaneous Dynamic Stabilization System with DSM’s Bionate(R) PCU
4/19/2011 10:18:38 AM
BERKELEY, Calif.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science, today announced the company has entered into a license and supply agreement with orthopedic device manufacturer Interventional Spine Inc.
The agreement grants Interventional Spine Inc. the use of Bionate® PCU, a proprietary DSM polymer, in its PDS System™. The Percutaneous Dynamic Stabilization system is the first and only percutaneous bilateral facet-augmentation system for treating degenerative disc disease and Lumbar Spinal Stenosis. The Interventional Spine PDS System™ implant is delivered percutaneously through the skin, making the over-the-wire procedure minimally invasive for the patient. The tough, load bearing qualities of Bionate® PCU help secure the implant in place as it flexes with the natural movement of the spine. Terms of the license and supply agreement were not disclosed, but contain a mix of royalties on devices sold and annual fees.
comments powered by